ArticleJournal of experimental & clinical cancer research : CR2020

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo.

Xueyin Zu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.